145 / 330
145
19–22 APRIL, 2017, BARCELONA, SPAIN
08:28–08:33
S13-7 (VP)
★
ROBOTIC RETROPERITONEAL LYMPHADENECTOMY
IN PARATESTICULAR RHABDOMYOSARCOMA
Enver MONCADA, Anna BUJONS, Erika LLORENS DE KNECHT, Jorge CAFFARATTI
and Humberto VILLAVICENCIO
Fundació Puigvert, Pediatric Urology, Barcelona, SPAIN
INTRODUCTION
The paratesticular sarcoma is an aggressive malignant tumor of mesenchymal origin. The rhab-
domyosarcoma is the most common among children. Rhabdomyosarcoma treatment consists
of surgery, chemotherapy and radiotherapy. Prognostic depends on local recurrence and distant
metastasis.
MATERIAL AND METHODS
We present the case of a 16-year-old man, who in April 2016 underwent right radical orchiectomy
surgery by testicular mass rapidly evolving, with pathological results indicating a paratesticular
rhabdomyosarcoma. The extension study showed a precaval adenopathy suggestive of lymph
node metastasis, therefore it was a high-grade rhabdomyosarcoma. There was an appropriate
response after chemotherapy (Protocol EpSSG RMS2005) and we decided to perform a robotic
lymphadenectomy.
RESULTS
We performed a transperitoneal approach with 8 mm trocar and 12 mm optica trocar. We accessed
to retroperitoneal space through at latero-colic incision. Then we performed a craniocaudal lymph
node disection until the aortic bifurcation. The surgical time was 240 minutes with a blood loss of
200 ml. There were no complications. The patient was discharged on the fourth day after surgery.
Pathology showed metastasis of rhabdomyosarcoma without capsular rupture. After two months,
we placed the left testicle into inguinal canal prior to radiotherapy.
CONCLUSIONS
Robotic lymph node metastasis lymphadenectomy from paratesticular sarcomas is a feasible treat-
ment with the advantage of minimally invasive surgery and acceptable morbidity.
08:33–08:42
Discussion